Radiomic signature: a non-invasive biomarker for discriminating invasive and non-invasive cases of lung adenocarcinoma

References

• Siegel R, Naishadham D. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.23335087
   PubMed Web of Science ®Google Scholar
• de Groot P. Lung cancer epidemiology, risk factors, and prevention. Radiol Clin North Am. 2012;50(5):863–876.22974775
   PubMed Web of Science ®Google Scholar
• Gazdar AF, Thun MJ. Lung cancer: smoke exposure and sex. Clin Oncol. 2007;25(5):469–471.
   Web of Science ®Google Scholar
• Rudin CM, Avila-Tang E, Harris CC, et al. Lung cancer in never smokers:molecular profiles and therapeutic implications. Clin Cancer Res. 2009;15(18):5646–5661.19755392
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244–285.21252716
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/American thoracic society/European respiratory society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc. 2011;8(5):381–385.21926387
   PubMedGoogle Scholar
• Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol. 2011;24(5):653–664.21252858
   PubMed Web of Science ®Google Scholar
• Russell PA, Wainer Z, Wright GM, et al. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new international association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol. 2011;6(9):1496–1504.21642859
   PubMed Web of Science ®Google Scholar
• Luo J, Huang Q, Wang R, et al. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB. J Cancer Res Clin Oncol. 2016;142(9):2031–2040.27379889
   PubMed Web of Science ®Google Scholar
• Yanagawa N, Shiono S, Abiko M, et al. New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma. J Thorac Oncol. 2013;8(5):612–618.23584293
   PubMed Web of Science ®Google Scholar
• Yoshiya T, Mimae T, Tsutani Y, et al. Prognostic role of subtype classification in small-sized pathologic N0 invasive lung adenocarcinoma. Ann Thorac Surg. 2016;102(5):1668–1673.27344277
   PubMed Web of Science ®Google Scholar
• Song Z, Zhu H, Guo Z, et al. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients–based on a hospital study in China. Eur J Surg Oncol. 2013;39(11):1262–1268.24063970
   PubMed Web of Science ®Google Scholar
• Fan L, Fang M, Li Z, et al. Radiomics signature: a biomarker for the preoperative discrimination of lung invasive adenocarcinoma manifesting as a ground-glass nodule. Eur Radiol. 2019;29(2):889–897.29967956
   PubMed Web of Science ®Google Scholar
• Dou TH, Coroller TP, van Griethuysen JJM, et al. Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC. PLoS One. 2018;13(11):e0206108.30388114
   PubMed Web of Science ®Google Scholar
• Kumar V, Gu Y, Basu S, et al. Radiomics: the process and the challenges. Magn Reson Imaging. 2012;30(9):1234–1248.22898692
   PubMed Web of Science ®Google Scholar
• Gillies RJ, Kinahan PE. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563–577.26579733
   PubMed Web of Science ®Google Scholar
• Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749–762.28975929
   PubMed Web of Science ®Google Scholar
• Keek SA, Leijenaar RT, Jochems A. A review on radiomics and the future of theranostics for patient selection in precision medicine. Br J Radiol. 2018;91(1091):20170926.29947266
   PubMed Web of Science ®Google Scholar
• Lee G, Lee HY, Park H, et al. Radiomics and its emerging role in lung cancer research, imaging biomarkers and clinical management: state of the art. Eur J Radiol. 2017;86:297–307.27638103
   PubMed Web of Science ®Google Scholar
• Nair VS, Gevaert O, Davidzon G, Plevritis SK, West R. NF-κB protein expression associates with (18)F-FDG PET tumor uptake in non-small cell lung cancer: a radiogenomics validation study to understand tumor metabolism. Lung Cancer. 2014;83(2):189–196.24355259
   PubMed Web of Science ®Google Scholar
• Austin JH, Garg K, Aberle D, et al. Radiologic implications of the 2011 classification of adenocarcinoma of the lung. Radiology. 2013;266(1):62–71.23070271
   PubMed Web of Science ®Google Scholar
• Song Z, Zhu H, Guo Z, et al. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China. Eur J Surg Oncol. 2013;39(11):1262–1268
   Google Scholar
• Ohtaki Y, Yoshida J, Ishii G, et al. Prognostic significance of a solid component in pulmonary adenocarcinoma. Ann Thorac Surg. 2011;91(4):1051–1057.21440121
   PubMed Web of Science ®Google Scholar
• Sakakura N, Inaba Y, Yatabe Y, et al. Estimation of the pathological invasive size of pulmonary adenocarcinoma using high-resolution computed tomography of the chest: a consideration based on lung and mediastinal window settings. Lung Cancer. 2016;95:51–56.27040852
   PubMed Web of Science ®Google Scholar
• Saji H, Matsubayashi J, Akata S, et al. Correlation between whole tumor size and solid component size on high-resolution computed tomography in the prediction of the degree of pathologic malignancy and the prognostic outcome in primary lung adenocarcinoma. Acta Radiol. 2015;56(10):1187–1195.25344503
   PubMed Web of Science ®Google Scholar
• Kitami A, Sano F, Hayashi S, et al. Correlation between histological invasiveness and the computed tomography value in pure ground-glass nodules. Surg Today. 2016;46(5):593–598.26123755
   PubMed Web of Science ®Google Scholar
• Nomori H, Ohtsuka T, Naruke T. Differentiating between atypical adenomatous hyperplasia and bronchioloalveolar carcinoma using the computed tomography number histogram. Ann Thorac Surg. 2003;76(3):867–871.12963218
   PubMed Web of Science ®Google Scholar
• Son JY, Lee HY, Lee KS, et al. Quantitative CT analysis of pulmonary ground-glass opacity nodules for the distinction of invasive adenocarcinoma from pre-invasive or minimally invasive adenocarcinoma. PLoS One. 2014;9(8):e104066.25102064
   PubMed Web of Science ®Google Scholar
• Wu W, Parmar C, Grossmann P, et al. Exploratory study to identify radiomics classifiers for lung cancer histology. Front Oncol. 2016;6:71.27064691
   PubMed Web of Science ®Google Scholar
• Haga A, Takahashi W, Aoki S, et al. Classification of early stage non-small cell lung cancers on computed tomographic images into histological types using radiomic features: interobserver delineation variability analysis. Radiol Phys Technol. 2018;11(1):27–35.29209915
   PubMed Web of Science ®Google Scholar
• Li W, Wang X, Zhang Y, et al. Radiomic analysis of pulmonary ground-glass opacity nodules for distinction of preinvasive lesions, invasive pulmonary adenocarcinoma and minimally invasive adenocarcinoma based on quantitative texture analysis of CT. Chin J Cancer Res. 2018;30(4):415–424.30210221
   PubMed Web of Science ®Google Scholar
• Chae HD, Park CM, Park SJ, et al. Computerized texture analysis of persistent part-solid ground-glass nodules: differentiation of preinvasive lesions from invasive pulmonary adenocarcinomas. Radiology. 2014;273(1):285–293.25102296
   PubMed Web of Science ®Google Scholar